<DOC>
	<DOCNO>NCT00004438</DOCNO>
	<brief_summary>RATIONALE : Hypogonadotropism abnormal condition cause decreased production gonadotropin , group hormone stimulate part reproductive system produce release eggs ovary sperm testicle . Leuprolide may stimulate production gonadotropin effective increase testosterone men induce ovulation woman . PURPOSE : Clinical trial study effectiveness leuprolide treat adult hypogonadotropism .</brief_summary>
	<brief_title>Leuprolide Treating Adults With Hypogonadotropism</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Male patient receive leuprolide subcutaneously every 5 day one year follow week 4 , 6 , 8 , 12 , every 2 month . Female patient receive leuprolide subcutaneously day 1 , 6 , possibly 11 . Patients follow 2 month last injection . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis hypogonadotropism Men : Small testis , abnormal semen analysis , subnormal plasma testosterone level without elevation gonadotropin level Women : Amenorrhea subnormal plasma estradiol level , lack cornification vaginal mucosa without elevation gonadotropin level OR Hypothalamic amenorrhea normally estrogenized woman amenorrhea oligomenorrhea normal plasma free testosterone gonadotropin level Patients hyperprolactinemia eligible hypogonadotropism persist correction hyperprolactinemia dopamine agonist therapy Prior/Concurrent Therapy At least 2 month since sex hormone treatment Patient Characteristics Other : Not pregnant No chronic systemic , metabolic , endocrine disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 1998</verification_date>
	<keyword>endocrine disorder</keyword>
	<keyword>hypogonadism</keyword>
	<keyword>rare disease</keyword>
</DOC>